BioTelemetry, Inc. (NASDAQ:BEAT)
BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual’s health. It is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. BioTelemetry, Inc., formerly known as CardioNet, Inc., is headquartered in Conshohocken, Pennsylvania.
BioTelemetry, Inc. (NASDAQ:BEAT)’s Financial Overview
BioTelemetry, Inc. (NASDAQ) surged 2.85% yesterday to close its trading session at $74.4. The company has 1 year Price Target of $77. BioTelemetry, Inc. has 52-Week high of $80.92 and 52-Week Low of $29.85. The stock touched its 52-Week High on 80.92 and 52-Week Low on 29.85. The stock traded with the volume of 640293 shares yesterday. The firm shows the market capitalization of $2.46 Billion.
BioTelemetry, Inc. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.53/share against the analyst consensus estimate of $0.32/share. The difference between the actual and expected EPS is $0.21 a share with a surprise factor of 65.6%.
The firm is trading with SMA20 of 5.71 Percent, SMA50 of 13.06 Percent and SMA200 of 33.33 percent. BioTelemetry, Inc. has P/S value of 6.35 while its P/B value stands at 8.31. Similarly, the company has Return on Assets of 3.1 percent, Return on Equity of 6.2 percent and Return on Investment of -0.2 Percent. The company shows Gross Margin and Operating Margin of 62.2 percent and 7.2 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 6 analysts offering 12-month price forecasts for BioTelemetry Inc have a median target of 76.00, with a high estimate of 90.00 and a low estimate of 66.00. The median estimate represents a +2.15% increase from the last price of 74.40.
BioTelemetry, Inc. is estimated to report earnings on 02/28/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.41. The reported EPS for the same quarter last year was $0.32.
Exela Technologies, Inc. (NASDAQ:XELA)
Exela Technologies, Inc. is engaged in providing information and transaction processing solutions. The Company’s segments include Information and Transaction Processing Solutions, Healthcare Solutions and Legal & Loss Prevention Services. ITPS provides industry solutions for banking and financial services, including lending solutions for mortgages, banking solutions for clearing, anti-money laundering, sanctions, cross-border settlement; property and casualty insurance solutions for enrollments, and communications. The HS segment offerings include integrated accounts payable and accounts receivable, and information management for both the healthcare payer and provider markets. The LLPS segment solutions include processing of legal claims for class action and mass action settlement administrations, involving project management support, notification and collection, analysis, and distribution of settlement funds. Exela Technologies Inc., formerly known as Quinpario Acquisition Corp. 2, is based in United States.
Exela Technologies, Inc. (NASDAQ:XELA)’s Financial Outlook
The 4 analysts offering 12-month price forecasts for Exela Technologies Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 4.50. The median estimate represents a +81.00% increase from the last price of 4.42.
Exela Technologies, Inc. is estimated to report earnings on 03/21/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.14. The reported EPS for the same quarter last year was $-0.08.
According to Zacks Investment Research, Exela Technologies, Inc. has a Consensus Recommendation of 1.75. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined -0.67% and closed its last trading session at $4.42. The company has the market capitalization of $641.92 Million. The stock has 52-week high of $7.34 and 52-Week low of $3.39. The firm touched its 52-Week high on 7.34 and 52-Week low on 3.39. The company has volume of 75025 shares. The company has a total of 145.23 Million shares outstanding.
Exela Technologies, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.2/share where the analyst estimated EPS was $-0.02/share. The difference between the actual and Estimated EPS is $-0.18. This shows a surprise factor of -900 percent.
The company has YTD performance of 13.62 percent. Beta for Exela Technologies, Inc. stands at 0.56 while its ATR (average true range) is 0.26. The company has Weekly Volatility of 6.51%% and Monthly Volatility of 6.69%%.
Exela Technologies, Inc. has distance from 20-day Simple Moving Average (SMA20) of 14.99%, Distance from 50-Day Simple Moving Average of 12.21 percent and Distance from 200-Day Simple Moving Average of -12.57%.
The Company currently has ROA (Return on Assets) of -8.3 percent, Return on Equity (ROE) of 280.9 Percent and Return on Investment (ROI) of -5.4% with Gross margin of 24.1 percent and Operating & Profit margin of -1.2% and -9% respectively.